Virosome-based technology platform
|
Virosomes are a market approved carrier and adjuvant system for the delivery of immunologically active substances. This predominantely synthetic carrier is broadly applicable with almost any antigen. Peptides, (recombinated) proteins or carbohydrates of interest are combined with a lipid anchor, which enables the attachment on the surface of virosomes: Modular virosome-based vaccine design
The virosome-based technology is validated by two marketed products (marketed by Berna a Crucell Company). These products are registered for human use in more than 42 countries, and they were administered to more than 41 million individuals: |
